Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Jose J, Kumar R, Harilal S et al. Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool. Environ. Sci. Pollut. Res. Int. 27(16), 19214–19225 (2020).
  MedlineGoogle Scholar
• 2. Bhayani KR, Rajwade JM, Paknikar KM. Radio frequency induced hyperthermia mediated by dextran stabilized LSMO nanoparticles: in vitro evaluation of heat shock protein response. Nanotechnology 24(1), (2013).
  MedlineGoogle Scholar
• 3. Jadhav Sv, Lee SH, Nikam DS et al. Studies on enhanced colloidal stability and heating ability of glycine functionalized LSMO nanoparticles for cancer hyperthermia therapy. New J. Chem. 41(4), 1598–1608 (2017).
  CASGoogle Scholar
• 4. Haghniaz R, Umrani RD, Paknikar KM. Hyperthermia mediated by dextran-coated La0. 7Sr0. 3MnO₃ nanoparticles: in vivo studies. Int. J. Nanomed. 11, 1779 (2016).
  Medline CASGoogle Scholar
• 5. Haghniaz R, Umrani RD, Paknikar KM. Temperature-dependent and time-dependent effects of hyperthermia mediated by dextran-coated La0.7Sr0.3MnO₃: in vitro studies. Int. J. Nanomed. 10, 1609–1623 (2015). •• Earlier report from our laboratory using lanthanum strontium manganese oxide (LSMO) nanoparticles as a hyperthermia agent.
  CASGoogle Scholar
• 6. Kriel J, Loos B. The good the bad and the autophagosome: exploring unanswered questions of autophagy-dependent cell death. Cell Death Diff. 26(4), 640–652 (2019).
  MedlineGoogle Scholar
• 7. Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 17(7), 395–417 (2020). •• Review explaining apoptotic pathways, the interaction between apoptotic pathways and therapeutic targets which can be aimed for cancer treatment.
  MedlineGoogle Scholar
• 8. Shi F, Luo D, Zhou X et al. Combined effects of hyperthermia and chemotherapy on the regulate autophagy of oral squamous cell carcinoma cells under a hypoxic microenvironment. Cell Death Diff. 7(1), 1–12 (2021).
  Google Scholar
• 9. Ali ES, Sharker SM, Islam MT et al. Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives. Semin. Cancer Biol. 69(August 2019), 52–68 (2021).
  Medline CASGoogle Scholar
• 10. Ji Y, Winter L, Navarro L et al. Controlled release of therapeutics from thermoresponsive nanogels: a thermal magnetic resonance feasibility study. Cancers (Basel) 12(6), 1380–1397 (2020).
  Medline CASGoogle Scholar
• 11. Carvalho C, Santos R, Cardoso S et al. Doxorubicin: the good, the bad and the ugly effect. Curr. Med. Chem. 16(25), 3267–3285 (2009).
  Medline CASGoogle Scholar
• 12. Zhao N, C Woodle M, Mixson AJ. Advances in delivery systems for doxorubicin. J. Nanomed. Nanotechnol. 09(05), 1–9 (2018).
  Google Scholar
• 13. Oei AL, Kok HP, Oei SB et al. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer. Adv. Drug. Deliv. Rev. 163–164, 84–97 (2020).
  Medline CASGoogle Scholar
• 14. Gavilán H, Avugadda SK, Fernández-Cabada T et al. Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer. Chem. Soc. Rev. 50(20), 11614–11667 (2021).
  Medline CASGoogle Scholar
• 15. Ahmed S, Rajak BL, Gogoi M, Sarma HD. Magnetic nanoparticles mediated cancer hyperthermia. INC Smart Healthcare for Disease Diagnosis and Prevention, Academic Press ISBN 9780128179130, 153–173 (2020).
  Google Scholar
• 16. Najafipour A, Gharieh A, Fassihi A et al. MTX-loaded dual thermoresponsive and pH-responsive magnetic hydrogel nanocomposite particles for combined controlled drug delivery and hyperthermia therapy of cancer. Mol. Pharm. 18(1), 275–284 (2021).
  Medline CASGoogle Scholar
• 17. Murugan C, Rayappan K, Thangam R et al. Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategies. Sci. Rep. 6(May), 1–17 (2016).
  MedlineGoogle Scholar
• 18. Moy AJ, Tunnell JW. Combinatorial immunotherapy and nanotticlse mediated hyperthermia. Adv. Drug Deliv. Rev. 114, 175–183 (2017).
  Medline CASGoogle Scholar
• 19. Arslan SA, Ozdemir N, Sendur MA et al. Hyperthermia and radiotherapy combination for locoregional recurrences of breast cancer: a review. Breast Cancer Manag. 6(4), 117–126 (2017).
  CASGoogle Scholar
• 20. Spirou Sv, Basini M, Lascialfari A et al. Magnetic hyperthermia and radiation therapy: radiobiological principles and current practice. Nanomaterials 8(6), 1–22 (2018).
  Google Scholar
• 21. Helderman RFCPA, Löke DR, Kok HP et al. Variation in clinical application of hyperthermic intraperitoneal chemotherapy: a review. Cancers (Basel) 11(1), 1–18 (2019).
  Google Scholar
• 22. Datta NR, Krishnan S, Speiser DE et al. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's ‘magic (nano)bullet’ for cancer theranostics? Cancer Treat. Rev. 50, 217–227 (2016).
  Medline CASGoogle Scholar
• 23. Auer RC, Sivajohanathan D, Biagi J et al. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review. Eur. J. Cancer 1, 76–95 (2020).
  Google Scholar
• 24. Yi GY, Kim MJ, Kim HI et al. Hyperthermia treatment as a promising anti-cancer strategy: therapeutic targets, perspective mechanisms and synergistic combinations in experimental approaches. Antioxidants 11(4), 625 (2022).
  Medline CASGoogle Scholar
• 25. Haghniaz R, Bhayani KR, Umrani RD, Paknikar KM. Dextran stabilized lanthanum strontium manganese oxide nanoparticles for magnetic resonance imaging. RSC Adv. 3(40), 18489–18497 (2013).
  CASGoogle Scholar
• 26. Thorat ND, Bohara RA, Noor MR et al. Effective cancer theranostics with polymer encapsulated superparamagnetic nanoparticles: combined effects of magnetic hyperthermia and controlled drug release. ACS Biomater. Sci. Eng. 3(7), 1332–1340 (2017). • Oleic acid and PEGylated LSMO nanoparticles as hyperthermia agents.
  Medline CASGoogle Scholar
• 27. Zhang J, Rana S, Srivastava RS, Misra RDK. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomaterialia 4(1), 40–48 (2008).
  Medline CASGoogle Scholar
• 28. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23(7), 1553–1561 (2002).
  Medline CASGoogle Scholar
• 29. Bekaroğlu MG, Alemdar A, İşçi S. Comparison of ionic polymers in the targeted drug delivery applications as the coating materials on the Fe₃O₄ nanoparticles. Mater. Sci. Eng. C 103(May), 109838–109844 (2019).
  Medline CASGoogle Scholar
• 30. Erdem M, Yalcin S, Gunduz U. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: preparation, characterization and cytotoxicity on HeLa cell line. Hum. Exp. Toxicol. 36(8), 833–845 (2017).
  Medline CASGoogle Scholar
• 31. Nilangekar K, Murmu N, Sahu G, Shravage BV. Generation and characterization of germline-specific autophagy and mitochondrial reactive oxygen species reporters in Drosophila. Front. Cell Dev. Biol. 7(APR), 1–18 (2019).
  MedlineGoogle Scholar
• 32. Elengoe A, Hamdan S. Hyperthermia and its clinical application in cancer treatment. Int. J. Adv. Life Sci. Res. 1(1), 22–27 (2018).
  Google Scholar
• 33. Peeken JC, Vaupel P, Combs SE. Integrating hyperthermia into modern radiation oncology: what evidence is necessary? Front. Oncol. 7(June), 132–149 (2017).
  MedlineGoogle Scholar
• 34. Dunne M, Regenold M, Allen C. Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy. Adv. Drug Deliv. Rev. 163–164, 98–124 (2020).
  Medline CASGoogle Scholar
• 35. Payne M, Bossmann SH, Basel MT. Direct treatment versus indirect: thermo-ablative and mild hyperthermia effects. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 12(5), 1–20 (2020).
  Google Scholar
• 36. Fernández M, Javaid F, Chudasama V. Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem. Sci. 9(4), 790–810 (2018).
  Medline CASGoogle Scholar
• 37. Cihoric N, Tsikkinis A, van Rhoon G et al. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int. J. Hyperther. 31(6), 609–614 (2015).
  Medline CASGoogle Scholar
• 38. Kulkarni VM, Bodas D, Dhoble D et al. Radio-frequency triggered heating and drug release using doxorubicin-loaded LSMO nanoparticles for bimodal treatment of breast cancer. Colloids Surf. B Biointerfaces 145, 878–890 (2016).
  Medline CASGoogle Scholar
• 39. Adityan S, Tran M, Bhavsar C, Wu SY. Nano-therapeutics for modulating the tumour microenvironment: design, development, and clinical translation. J. Control. Rel. 327(April), 512–532 (2020).
  Medline CASGoogle Scholar
• 40. Shi J, Chen Z, Wang L et al. A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and x-ray imaging. Acta Biomaterialia 29, 282–297 (2016).
  Medline CASGoogle Scholar
• 41. Liu JF, Neel N, Dang P et al. Radiofrequency‐triggered drug release from nanoliposomes with millimeter‐scale resolution using a superimposed static gating field. Small 14(44), 1802563 (2018).
  Google Scholar
• 42. Radmansouri M, Bahmani E, Sarikhani E et al. Doxorubicin hydrochloride – loaded electrospun chitosan/cobalt ferrite/titanium oxide nanofibers for hyperthermic tumor cell treatment and controlled drug release. Int. J. Biol. Macromol. 116, 378–384 (2018).
  Medline CASGoogle Scholar
• 43. Arfin S, Jha NK, Jha SK et al. Oxidative stress in cancer cell metabolism. Antioxidants 10(5), 1–28 (2021). •• Illustrative review explaining the role of oxidative stress in cancer.
  Google Scholar
• 44. Wu H, Liu L, Song L et al. Enhanced tumor synergistic therapy by injectable magnetic hydrogel mediated generation of hyperthermia and highly toxic reactive oxygen species. ACS Nano 13(12), 14013–14023 (2019).
  Medline CASGoogle Scholar
• 45. Khan A, Sahu NK. Hydrazone conjugated and DOX loaded PEGylated-Fe₃O₄ mesoporous magnetic nanoclusters (MNCs): hyperthermia and in vitro chemotherapy. New J. Chem. 45(46), 21646–21656 (2021).
  CASGoogle Scholar
• 46. Hsu FT, Chiang IT, Wang WS. Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-κB signalling participate in anti-glioblastoma of imipramine. J. Cell. Mol. Med. 24(7), 3982–4000 (2020).
  Medline CASGoogle Scholar
• 47. Bandyopadhyay A, Roy B, Shaw P et al. Chitosan-gold nanoparticles trigger apoptosis in human breast cancer cells in vitro. Nucleus (India) 64(1), 79–92 (2021).
  CASGoogle Scholar
• 48. Abdel-Hakeem MA, Abdel-Haseb OM, Abdel-Ghany SE et al. Doxorubicin loaded on chitosan-protamine nanoparticles triggers apoptosis via downregulating Bcl-2 in breast cancer cells. J. Drug Deliv. Sci. Technol. 55, 101423 (2020).
  CASGoogle Scholar
• 49. Wu Z, Wang T, Zhang Y et al. Anticancer effects of β-elemene with hyperthermia in lung cancer cells. Exp. Ther. Med. 13(6), 3153–3157 (2017).
  Medline CASGoogle Scholar
• 50. Aubrey BJ, Kelly GL, Janic A et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 25(1), 104–113 (2018).
  Medline CASGoogle Scholar
• 51. Helderman RF, Löke DR, Verhoeff J et al. The temperature-dependent effectiveness of platinum-based drugs mitomycin-C and 5-FU during hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer cell lines. Cells. 9(8), 1775 (2020).
  Medline CASGoogle Scholar
• 52. Tompkins KD, Thorburn A. Regulation of apoptosis by autophagy to enhance cancer therapy. Yale J Biol. Med. 92(4), 707–718 (2019). • Crosstalk between autophagy and apoptosis.
  Medline CASGoogle Scholar
• 53. Mulcahy Levy JM, Thorburn A. Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ. 27(3), 843–857 (2020).
  MedlineGoogle Scholar
• 54. Liu Y, Zhong Y, Tian W et al. An autophagy-dependent cell death of MDA-MB-231 cells triggered by a novel Rhein derivative 4F. Anti-Cancer Drugs 30(10), 1038–1047 (2019).
  Medline CASGoogle Scholar
• 55. Chen C, Lu L, Yan S et al. Autophagy and doxorubicin resistance in cancer. Anti-Cancer Drugs 29(1), 1–9 (2018).
  MedlineGoogle Scholar
• 56. Bordi M, de Cegli R, Testa B et al. A gene toolbox for monitoring autophagy transcription. Cell Death Dis. 12(11), 1–7 (2021). • Explains gene targets for monitoring cell autophagy.
  MedlineGoogle Scholar
• 57. Guo Y, Pei X. Tetrandrine-induced autophagy in MDA-MB-231 triple-negative breast cancer cell through the inhibition of PI3K/AKT/mTOR signaling. Evid. Based Complement. Alternat. Med. 2019, 7517431 (2019).
  MedlineGoogle Scholar
• 58. Fairlie WD, Tran S, Lee EF. Crosstalk between apoptosis and autophagy signaling pathways. Int. Rev. Cell Mol. Biol. 352, 115–158 (2020).
  MedlineGoogle Scholar
• 59. Russo R, Berliocchi L, Adornetto A et al. Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo. Cell Death Dis. 2(4), e144–9 (2011).
  Medline CASGoogle Scholar
• 60. Gao L, Loveless J, Shay C, Teng Y. Targeting ROS-mediated crosstalk between autophagy and apoptosis in cancer. Rev. New Drug Targets Age-Related Disord. 2020, 1–2 (2020).
  Google Scholar